Physician profile
Johnny Cai
NPI 1861998452
$1,284.57
in general payments reported to CMS, 2019-2025
19 companies · $365 in 2025
The $365 reported for 2025 was less than what a typical Hematology & Oncology provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $116 · 2022: $96.10 · 2023: $464 · 2024: $244 · 2025: $365.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $981 · Education: $90.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $981.36 |
| Education | $90.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $181.48 | 2024-2025 | |
| Astellas Pharma US INC | $169.64 | 2023-2025 | Xospata, Vyloy |
| Celgene Corporation | $158.70 | 2022-2025 | Pomalyst |
| Incyte Corporation | $126.54 | 2021-2023 | Jakafi |
| Seagen INC. | $108.64 | 2021-2023 | Adcetris, Tukysa |
| Astrazeneca Pharmaceuticals LP | $93.22 | 2023-2025 | Enhertu, Lynparza, Tagrisso |
| Takeda Pharmaceuticals U.S.A., INC. | $93.16 | 2025 | Iclusig |
| Daiichi Sankyo INC. | $48.74 | 2025 | Enhertu |
| Alexion Pharmaceuticals, INC. | $45.45 | 2023-2024 | Ultomiris |
| Abbvie INC. | $34.48 | 2025 | |
| Karyopharm Therapeutics INC. | $33.62 | 2023 | Xpovio |
| Immunogen, INC. | $29.21 | 2023 | Elahere |
| Teleflex LLC | $28.99 | 2024 | Arrow |
| Eisai INC. | $26.07 | 2025 | |
| Genzyme Corporation | $25.51 | 2023 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $23.21 | 2025 | Rybrevant |
| E.R. Squibb & Sons, L.L.C. | $20.08 | 2025 | Opdivo |
| Mirati Therapeutics, INC. | $19.96 | 2023 | Krazati |
| Glaxosmithkline, LLC. | $17.87 | 2025 | Ojjaara |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Johnny Cai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.